Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Catalent Expands Madison, Wisconsin, Production Operations

07/21/2025
Catalent, a provider of drug delivery technologies, drug development, drug manufacturing, biologics, gene therapy, and consumer health products, plans to expand its operations in Madison, Wisconsin. The $45 million project is expected to create approximately 200 jobs.

The investment will include the purchase of new equipment at the company’s existing production facility which provides development, manufacturing, and analytical services for new biological therapies.

“We are proud to expand our operations in Wisconsin, a growing hub for innovation and collaboration, enabling us to advance the important work we do for pharma and biotech customers and the patients they serve,” said Catalent Group President of Biologics David McErlane. “We have enjoyed a supportive business environment and access to skilled talent in Madison, and we look forward to Catalent’s continued presence and growth in Wisconsin.”

The project is being supported by the Wisconsin Economic Development Corporation (WEDC) with up to $2 million in performance-based business development tax credits. The actual amount of tax credits received is contingent upon the number of jobs created and the amount of capital investment during that period.

“Catalent’s continued growth in Madison is not only good news for the company, but for the entire state,” noted WEDC Secretary and CEO Missy Hughes. “The company knows it can find the skilled workforce they need while the state continues to expand its lead as a powerhouse in the field of biohealth.”

Catalent, a subsidiary of Novo Holdings A/S since 2024, partners with pharmaceutical, biotech, and consumer health companies to optimize product development, launch, and lifecycle management. The company provides a range of services, including formulation development, manufacturing, and packaging, with a focus on enhancing drug efficacy and patient outcomes.

Exclusive Research